Is DCTH or ENOV more profitable?

Delcath Systems has a net margin of 0.56% compared to Enovis' net margin of -47.96%. Enovis' return on equity of 12.03% beat Delcath Systems' return on equity. Company Net Margins Return on Equity Return on Assets Delcath Systems 0.56% 0.47% 0.43% Enovis -47.96% 12.03% 4.91%

Does the media refer more to DCTH or ENOV?

In the previous week, Enovis had 7 more articles in the media than Delcath Systems. MarketBeat recorded 24 mentions for Enovis and 17 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.88 beat Enovis' score of 0.58 indicating that Delcath Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 4 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Enovis 4 Very Positive mention(s) 5 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor OMCL or DCTH?

In the previous week, Delcath Systems had 10 more articles in the media than Omnicell. MarketBeat recorded 17 mentions for Delcath Systems and 7 mentions for Omnicell. Delcath Systems' average media sentiment score of 0.88 beat Omnicell's score of 0.69 indicating that Delcath Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omnicell 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Delcath Systems 4 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is ATEC or DCTH more profitable?

Delcath Systems has a net margin of 0.56% compared to Alphatec's net margin of -13.49%. Delcath Systems' return on equity of 0.47% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets Alphatec -13.49% -6,752.24% -13.88% Delcath Systems 0.56% 0.47% 0.43%

Does the media prefer ATEC or DCTH?

In the previous week, Alphatec had 5 more articles in the media than Delcath Systems. MarketBeat recorded 22 mentions for Alphatec and 17 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.88 beat Alphatec's score of 0.62 indicating that Delcath Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alphatec 9 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Delcath Systems 4 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, CNMD or DCTH?

CONMED has higher revenue and earnings than Delcath Systems. CONMED is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CONMED $1.37B 1.07 $47.06M $1.85 26.48 Delcath Systems $85.23M 6.12 $2.70M $0.01 1,511.00

Does the media favor CNMD or DCTH?

In the previous week, Delcath Systems had 12 more articles in the media than CONMED. MarketBeat recorded 17 mentions for Delcath Systems and 5 mentions for CONMED. CONMED's average media sentiment score of 1.23 beat Delcath Systems' score of 0.88 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Delcath Systems 4 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate NNNN or DCTH?

Delcath Systems has a consensus price target of $23.17, suggesting a potential upside of 53.32%. Given Delcath Systems' stronger consensus rating and higher probable upside, analysts clearly believe Delcath Systems is more favorable than Anbio Biotechnology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anbio Biotechnology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Delcath Systems 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57

Which has higher valuation and earnings, NNNN or DCTH?

Anbio Biotechnology has higher earnings, but lower revenue than Delcath Systems. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Anbio Biotechnology $8.65M 176.56 $6.40M N/A N/A Delcath Systems $85.23M 6.12 $2.70M $0.01 1,511.00

Delcath Systems (DCTH) Competitors

$15.11 -0.36 (-2.33%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$14.91 -0.20 (-1.32%)

As of 08/7/2026 07:36 PM Eastern

Compare

DCTH vs. ENOV, OMCL, ATEC, CNMD, and NNNN

Should you buy Delcath Systems stock or one of its competitors? MarketBeat compares Delcath Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Delcath Systems include Enovis (ENOV), Omnicell (OMCL), Alphatec (ATEC), CONMED (CNMD), and Anbio Biotechnology (NNNN). These companies are all part of the "healthcare equipment" industry.

How does Delcath Systems compare to Enovis?

Delcath Systems (NASDAQ:DCTH) and Enovis (NYSE:ENOV) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

Delcath Systems currently has a consensus price target of $23.17, suggesting a potential upside of 53.32%. Enovis has a consensus price target of $42.00, suggesting a potential upside of 57.39%. Given Enovis' stronger consensus rating and higher possible upside, analysts plainly believe Enovis is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Enovis	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

Delcath Systems has higher earnings, but lower revenue than Enovis. Enovis is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	6.12	$2.70M	$0.01	1,511.00
Enovis	$2.25B	0.68	-$1.18B	-$19.88	N/A

In the previous week, Enovis had 7 more articles in the media than Delcath Systems. MarketBeat recorded 24 mentions for Enovis and 17 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.88 beat Enovis' score of 0.58 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Enovis	4 Very Positive mention(s)	5 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 98.5% of Enovis shares are held by institutional investors. 19.4% of Delcath Systems shares are held by company insiders. Comparatively, 2.9% of Enovis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Delcath Systems has a net margin of 0.56% compared to Enovis' net margin of -47.96%. Enovis' return on equity of 12.03% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.56%	0.47%	0.43%
Enovis	-47.96%	12.03%	4.91%

Delcath Systems has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, Enovis has a beta of 1.34, suggesting that its stock price is 34% more volatile than the broader market.

Summary

Enovis beats Delcath Systems on 9 of the 16 factors compared between the two stocks.

How does Delcath Systems compare to Omnicell?

Omnicell (NASDAQ:OMCL) and Delcath Systems (NASDAQ:DCTH) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

Omnicell currently has a consensus price target of $57.86, indicating a potential upside of 57.18%. Delcath Systems has a consensus price target of $23.17, indicating a potential upside of 53.32%. Given Omnicell's stronger consensus rating and higher possible upside, analysts clearly believe Omnicell is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Omnicell has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.52, indicating that its stock price is 48% less volatile than the broader market.

97.7% of Omnicell shares are held by institutional investors. Comparatively, 61.1% of Delcath Systems shares are held by institutional investors. 2.9% of Omnicell shares are held by insiders. Comparatively, 19.4% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Delcath Systems had 10 more articles in the media than Omnicell. MarketBeat recorded 17 mentions for Delcath Systems and 7 mentions for Omnicell. Delcath Systems' average media sentiment score of 0.88 beat Omnicell's score of 0.69 indicating that Delcath Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omnicell	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
Delcath Systems	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Delcath Systems has lower revenue, but higher earnings than Omnicell. Omnicell is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.18B	1.41	$2.05M	$0.84	43.82
Delcath Systems	$85.23M	6.12	$2.70M	$0.01	1,511.00

Omnicell has a net margin of 3.13% compared to Delcath Systems' net margin of 0.56%. Omnicell's return on equity of 5.66% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omnicell	3.13%	5.66%	3.57%
Delcath Systems	0.56%	0.47%	0.43%

Summary

Omnicell beats Delcath Systems on 10 of the 16 factors compared between the two stocks.

How does Delcath Systems compare to Alphatec?

Alphatec (NASDAQ:ATEC) and Delcath Systems (NASDAQ:DCTH) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Delcath Systems has lower revenue, but higher earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alphatec	$764.16M	1.88	-$143.36M	-$0.71	N/A
Delcath Systems	$85.23M	6.12	$2.70M	$0.01	1,511.00

In the previous week, Alphatec had 5 more articles in the media than Delcath Systems. MarketBeat recorded 22 mentions for Alphatec and 17 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.88 beat Alphatec's score of 0.62 indicating that Delcath Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alphatec	9 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Delcath Systems	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Delcath Systems has a net margin of 0.56% compared to Alphatec's net margin of -13.49%. Delcath Systems' return on equity of 0.47% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alphatec	-13.49%	-6,752.24%	-13.88%
Delcath Systems	0.56%	0.47%	0.43%

66.4% of Alphatec shares are held by institutional investors. Comparatively, 61.1% of Delcath Systems shares are held by institutional investors. 13.5% of Alphatec shares are held by company insiders. Comparatively, 19.4% of Delcath Systems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Alphatec currently has a consensus target price of $17.40, suggesting a potential upside of 86.90%. Delcath Systems has a consensus target price of $23.17, suggesting a potential upside of 53.32%. Given Alphatec's stronger consensus rating and higher possible upside, research analysts plainly believe Alphatec is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alphatec	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Alphatec has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.52, meaning that its stock price is 48% less volatile than the broader market.

Summary

Delcath Systems beats Alphatec on 9 of the 16 factors compared between the two stocks.

How does Delcath Systems compare to CONMED?

CONMED (NYSE:CNMD) and Delcath Systems (NASDAQ:DCTH) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

CONMED has a net margin of 4.12% compared to Delcath Systems' net margin of 0.56%. CONMED's return on equity of 14.31% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
Delcath Systems	0.56%	0.47%	0.43%

CONMED has higher revenue and earnings than Delcath Systems. CONMED is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	1.07	$47.06M	$1.85	26.48
Delcath Systems	$85.23M	6.12	$2.70M	$0.01	1,511.00

CONMED has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market.

In the previous week, Delcath Systems had 12 more articles in the media than CONMED. MarketBeat recorded 17 mentions for Delcath Systems and 5 mentions for CONMED. CONMED's average media sentiment score of 1.23 beat Delcath Systems' score of 0.88 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Delcath Systems	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

61.1% of Delcath Systems shares are held by institutional investors. 0.3% of CONMED shares are held by company insiders. Comparatively, 19.4% of Delcath Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

CONMED presently has a consensus target price of $41.40, suggesting a potential downside of 15.50%. Delcath Systems has a consensus target price of $23.17, suggesting a potential upside of 53.32%. Given Delcath Systems' stronger consensus rating and higher possible upside, analysts clearly believe Delcath Systems is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.63
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Summary

CONMED and Delcath Systems tied by winning 8 of the 16 factors compared between the two stocks.

How does Delcath Systems compare to Anbio Biotechnology?

Anbio Biotechnology (NASDAQ:NNNN) and Delcath Systems (NASDAQ:DCTH) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

Delcath Systems has a consensus price target of $23.17, suggesting a potential upside of 53.32%. Given Delcath Systems' stronger consensus rating and higher probable upside, analysts clearly believe Delcath Systems is more favorable than Anbio Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anbio Biotechnology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Delcath Systems	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

In the previous week, Delcath Systems had 17 more articles in the media than Anbio Biotechnology. MarketBeat recorded 17 mentions for Delcath Systems and 0 mentions for Anbio Biotechnology. Delcath Systems' average media sentiment score of 0.88 beat Anbio Biotechnology's score of 0.00 indicating that Delcath Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
Anbio Biotechnology	Neutral
Delcath Systems	Positive

61.1% of Delcath Systems shares are held by institutional investors. 19.4% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Anbio Biotechnology has a beta of 5.4, meaning that its share price is 440% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

Delcath Systems has a net margin of 0.56% compared to Anbio Biotechnology's net margin of 0.00%. Delcath Systems' return on equity of 0.47% beat Anbio Biotechnology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anbio Biotechnology	N/A	N/A	N/A
Delcath Systems	0.56%	0.47%	0.43%

Anbio Biotechnology has higher earnings, but lower revenue than Delcath Systems.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anbio Biotechnology	$8.65M	176.56	$6.40M	N/A	N/A
Delcath Systems	$85.23M	6.12	$2.70M	$0.01	1,511.00

Summary

Delcath Systems beats Anbio Biotechnology on 11 of the 14 factors compared between the two stocks.

Get Delcath Systems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DCTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DCTH vs. The Competition

Export

Metric	Delcath Systems	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$521.63M	$5.84B	$7.03B	$13.02B
Dividend Yield	N/A	1.78%	2.58%	10.20%
P/E Ratio	1,512.51	24.26	271.11	25.19
Price / Sales	6.12	61.97	593.39	82.79
Price / Cash	289.05	33.10	71.81	50.72
Price / Book	4.80	5.70	13.25	6.22
Net Income	$2.70M	$148.58M	$3.45B	$342.66M
7 Day Performance	23.65%	4.75%	4.67%	4.41%
1 Month Performance	11.76%	0.71%	-1.28%	-1.10%
1 Year Performance	50.95%	4.93%	77.33%	23.99%

Delcath Systems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DCTH Delcath Systems	3.1079 of 5 stars	$15.11 -2.3%	$23.17 +53.3%	+50.9%	$521.63M	$85.23M	1,512.51	60	Trending News Earnings Report Analyst Forecast Analyst Revision High Trading Volume
ENOV Enovis	4.1994 of 5 stars	$30.85 -1.8%	$41.86 +35.7%	-6.3%	$1.78B	$2.25B	N/A	7,802	Trending News Earnings Report Analyst Forecast Gap Up
OMCL Omnicell	4.0324 of 5 stars	$37.11 -1.4%	$57.86 +55.9%	+19.4%	$1.69B	$1.18B	44.24	3,580	Analyst Forecast
ATEC Alphatec	4.0015 of 5 stars	$10.14 -0.1%	$17.13 +68.9%	-37.8%	$1.56B	$764.16M	N/A	700	News Coverage Earnings Report Analyst Forecast
CNMD CONMED	2.7112 of 5 stars	$50.47 -2.7%	$41.40 -18.0%	-10.4%	$1.51B	$1.37B	27.28	3,900	Positive News Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DCTH) was last updated on 8/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Delcath Systems (DCTH) Competitors

DCTH vs. ENOV, OMCL, ATEC, CNMD, and NNNN

How does Delcath Systems compare to Enovis?

Summary

How does Delcath Systems compare to Omnicell?

Summary

How does Delcath Systems compare to Alphatec?

Summary

How does Delcath Systems compare to CONMED?

Summary

How does Delcath Systems compare to Anbio Biotechnology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCTH vs. The Competition

Delcath Systems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Delcath Systems (DCTH) Competitors

DCTH vs. ENOV, OMCL, ATEC, CNMD, and NNNN

How does Delcath Systems compare to Enovis?

Do analysts prefer DCTH or ENOV?

Which has stronger valuation and earnings, DCTH or ENOV?

Does the media refer more to DCTH or ENOV?

Do insiders and institutionals believe in DCTH or ENOV?

Is DCTH or ENOV more profitable?

Which has more volatility and risk, DCTH or ENOV?

Summary

How does Delcath Systems compare to Omnicell?

Do analysts rate OMCL or DCTH?

Which has more volatility & risk, OMCL or DCTH?

Do institutionals and insiders believe in OMCL or DCTH?

Does the media favor OMCL or DCTH?

Which has stronger earnings and valuation, OMCL or DCTH?

Is OMCL or DCTH more profitable?

Summary

How does Delcath Systems compare to Alphatec?

Which has stronger earnings and valuation, ATEC or DCTH?

Does the media prefer ATEC or DCTH?

Is ATEC or DCTH more profitable?

Do institutionals & insiders believe in ATEC or DCTH?

Do analysts rate ATEC or DCTH?

Which has more volatility and risk, ATEC or DCTH?

Summary

How does Delcath Systems compare to CONMED?

Is CNMD or DCTH more profitable?

Which has higher earnings & valuation, CNMD or DCTH?

Which has more volatility and risk, CNMD or DCTH?

Does the media favor CNMD or DCTH?

Do institutionals and insiders hold more shares of CNMD or DCTH?

Do analysts recommend CNMD or DCTH?

Summary

How does Delcath Systems compare to Anbio Biotechnology?

Do analysts rate NNNN or DCTH?

Does the media prefer NNNN or DCTH?

Do institutionals & insiders have more ownership in NNNN or DCTH?

Which has more risk and volatility, NNNN or DCTH?

Is NNNN or DCTH more profitable?

Which has higher valuation and earnings, NNNN or DCTH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCTH vs. The Competition

Delcath Systems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools